Patterns of biologic agent utilization among patients with rheumatoid arthritis: a retrospective cohort study.
about
Claims Data Analysis of Tumor Necrosis Factor Inhibitor Treatment Dosing Among Patients with Rheumatoid Arthritis: A Systematic Review of MethodsComparative persistence of the TNF antagonists in rheumatoid arthritis--a population-based cohort studyDeterminants of biological drug survival in rheumatoid arthritis: evidence from a Hungarian rheumatology center over 8 years of retrospective data.Cost of tumor necrosis factor blockers per patient with rheumatoid arthritis in a multistate Medicaid populationDrug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis.Drug usage analysis and health care resources consumption in naïve patients with rheumatoid arthritis.Comparison of Healthcare Costs Between Rheumatoid Arthritis Patients Treated with Infused Biologics After Switching from Another Biologic.Comparison of Biologic Disease-Modifying Antirheumatic Drug Therapy Persistence Between Biologics Among Rheumatoid Arthritis Patients Switching from Another Biologic.Persistence with biologic agents for the treatment of rheumatoid arthritis in Japan.Treatment persistence in patients with rheumatoid arthritis and ankylosing spondylitis.Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune-mediated diseasesComparing Biologic Cost Per Treated Patient Across Indications Among Adult US Managed Care Patients: A Retrospective Cohort StudyTreatment patterns in the first year after initiating tumor necrosis factor blockers in real-world settings.Dose modification of anti-TNF in rheumatoid arthritis and estimated economical impact: a review of observational studies.Dose modifications of anti-TNF drugs in rheumatoid arthritis patients under real-world settings: a systematic review.Medication Persistence of Disease-Modifying Antirheumatic Drugs and Anti-Tumor Necrosis Factor Agents in a Cohort of Patients With Rheumatoid Arthritis in Brazil.Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry.Switching profiles in a population-based cohort of rheumatoid arthritis receiving biologic therapy: results from the KOBIO registry.The use of adalimumab, etanercept, golimumab and infliximab in rheumatic pathologies: variation between label dosage and real-world use.
P2860
Q28069373-2E545BE4-CC50-4211-8093-508FE3A73EF9Q28542423-7726533D-598E-446E-8572-B47EBBD92EE6Q31167447-C8506D8F-E784-49ED-8D88-6B863924B256Q34211985-95514FF9-F5BE-4E44-B056-DD75232140C5Q36099620-08C589CC-E0D2-4007-915C-FB7730929DD9Q36274355-B9D4976E-4DC0-4D28-BDFF-7CC69CBF068EQ36942874-BD0842FA-08A5-4F7B-B3F8-9CA4EE3A83B2Q36942952-8CE5A180-B1CF-4971-AA86-77A4D43C26ACQ37167818-21D5758F-71E0-42EA-BFF7-346E07A96C52Q37184062-CE8037A5-17B7-491B-A784-808F3E9486C2Q37186231-98CDA7B5-D18E-430F-BBCA-349B093FA6CAQ37452967-AE1C3CEB-CF50-459C-B28C-4F7D02FF628DQ38034134-443DE661-D55B-4DB6-9323-DE467DEBDC73Q38306139-09FB0A17-B3FC-4BBC-A5E7-A4D48C6D3841Q38338700-2B13AF88-15A4-47CF-819B-8FBFBC2F7D94Q38915704-0D87F71A-1B49-43B2-A253-7A88AD79644AQ38921982-95F39432-E4EC-43B0-9E46-8D6C5375A312Q40314992-C0F84CA1-262C-46CD-B934-5CE0E17DDAC2Q40942139-90AC368C-61E0-499C-A35F-A5DEBF5209D6
P2860
Patterns of biologic agent utilization among patients with rheumatoid arthritis: a retrospective cohort study.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Patterns of biologic agent uti ...... a retrospective cohort study.
@ast
Patterns of biologic agent uti ...... a retrospective cohort study.
@en
Patterns of biologic agent uti ...... a retrospective cohort study.
@nl
type
label
Patterns of biologic agent uti ...... a retrospective cohort study.
@ast
Patterns of biologic agent uti ...... a retrospective cohort study.
@en
Patterns of biologic agent uti ...... a retrospective cohort study.
@nl
prefLabel
Patterns of biologic agent uti ...... a retrospective cohort study.
@ast
Patterns of biologic agent uti ...... a retrospective cohort study.
@en
Patterns of biologic agent uti ...... a retrospective cohort study.
@nl
P2093
P2860
P356
P1476
Patterns of biologic agent uti ...... a retrospective cohort study.
@en
P2093
Elena Hitraya
Henry J Henk
Sarika Ogale
P2860
P2888
P356
10.1186/1471-2474-12-204
P577
2011-09-19T00:00:00Z
P5875
P6179
1007982993